| 000 | 01663 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250513184847.0 | ||
| 264 | 0 | _c19990715 | |
| 008 | 199907s 0 0 eng d | ||
| 022 | _a1087-0156 | ||
| 024 | 7 |
_a10.1038/9865 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFalcioni, F | |
| 245 | 0 | 0 |
_aPeptidomimetic compounds that inhibit antigen presentation by autoimmune disease-associated class II major histocompatibility molecules. _h[electronic resource] |
| 260 |
_bNature biotechnology _cJun 1999 |
||
| 300 |
_a562-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAmino Acid Sequence |
| 650 | 0 | 4 | _aAmino Acid Substitution |
| 650 | 0 | 4 |
_aAntigen Presentation _xdrug effects |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _ximmunology |
| 650 | 0 | 4 |
_aCathepsins _xmetabolism |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aHLA-DR Antigens _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHydrogen Bonding |
| 650 | 0 | 4 | _aMolecular Mimicry |
| 650 | 0 | 4 |
_aOligopeptides _xchemistry |
| 650 | 0 | 4 | _aProtein Binding |
| 650 | 0 | 4 |
_aT-Lymphocytes _xdrug effects |
| 700 | 1 | _aIto, K | |
| 700 | 1 | _aVidovic, D | |
| 700 | 1 | _aBelunis, C | |
| 700 | 1 | _aCampbell, R | |
| 700 | 1 | _aBerthel, S J | |
| 700 | 1 | _aBolin, D R | |
| 700 | 1 | _aGillespie, P B | |
| 700 | 1 | _aHuby, N | |
| 700 | 1 | _aOlson, G L | |
| 700 | 1 | _aSarabu, R | |
| 700 | 1 | _aGuenot, J | |
| 700 | 1 | _aMadison, V | |
| 700 | 1 | _aHammer, J | |
| 700 | 1 | _aSinigaglia, F | |
| 700 | 1 | _aSteinmetz, M | |
| 700 | 1 | _aNagy, Z A | |
| 773 | 0 |
_tNature biotechnology _gvol. 17 _gno. 6 _gp. 562-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/9865 _zAvailable from publisher's website |
| 999 |
_c10343671 _d10343671 |
||